Cough News and Research

RSS
Bacteria in babies' noses could offer clues to recovery from first cough or cold

Bacteria in babies' noses could offer clues to recovery from first cough or cold

Study examines trends in opioids prescribed for children and adolescents

Study examines trends in opioids prescribed for children and adolescents

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

New lung cancer guides aim to drive better outcomes and care

New lung cancer guides aim to drive better outcomes and care

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus announces availability of Arsenic Trioxide Injection in the US

Measles can be deadly for people with weakened immune systems

Measles can be deadly for people with weakened immune systems

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis

Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis

Immunotherapy increases survival in some patients with metastatic triple negative breast cancer

Immunotherapy increases survival in some patients with metastatic triple negative breast cancer

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Maternal Tdap immunization during third trimester linked with higher levels of pertussis antibodies in newborns

Maternal Tdap immunization during third trimester linked with higher levels of pertussis antibodies in newborns

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients